|
|
|
|
||
Regeneron says IDMC recommends halt of some REGN-COV2 trial enrollment for safety riskshttps://finance.yahoo.com/m/9ea1184d-2822-3542-80f7-7ee0795a1b50/regeneron-says-idmc.html Regeneron says IDMC recommends halt of some REGN-COV2 trial enrollment for safety risks Tomi Kilgore Fri, October 30, 2020, 6:33 AM PDT Shares of Regeneron Pharmaceuticals Inc. slumped 1.2% in morning trading Friday, after the biotechnology company said an independent data monitoring committee (IDMC) for the REGN-COV2 antibody cocktail treatment trials for COVID-19 recommended that the patient trial be "modified," with the enrollment of some patients place on hold. REGN-COV2 was one of the treatments prescribed to President Trump after he tested positive for COVID-19. Based on a "potential safety signal and an unfavorable risk/benefit profile at this time," the IDMC recommended that further enrollment of patients requiring high-flow oxygen or mechanical ventilation be placed on hold pending analysis of further data. The IDMC also recommends continuing enrollment of patients requiring no or low-flow oxygen and the continuation of the outpatient trial without modification. REGN-COV2 is currently being evaluated by the Food and Drug Administration for a potential Emergency Use Authorization in mild-to-moderate outpatients with high risk of poor outcomes. The stock has lost 13% over the past three months, while the S&P 500 has gained 1.6%. Story continues This so-called antibody cocktail was given to Trump. He was praising this antibody. What a Loser. A politician becomes the top scientist even on top of Dr.Fauci. IMO |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
194907 | Re: Regeneron says IDMC recommends halt of some REGN-COV2 trial enrollment for safety risks | Bobco | 2 | 10/30/2020 2:48:14 PM |